Restoration of miR-7 levels could have therapeutic potential, as miR-7 targets the mRNA of epidermal growth factor receptor (EGFR) and α-synuclein, which are overexpressed in brain tissue from GBM and PD patients, respectively [112,113,114]. This evidence concerns the gene EGFR and glioblastoma.